Glucose B.Braun

Glucose B.Braun is a sterile aqueous solution containing glucose monohydrate, supplied for intravenous injection. It is a parenteral carbohydrate product marketed in the European Union and prescribed by health‑care professionals for rapid provision of glucose to support cellular energy and fluid balance. The formulation is isotonic and may include electrolytes to aid in maintaining plasma osmolarity during therapy. It is supplied in single‑use vials for safe handling.

Glucose B.Braun is used in clinical settings where rapid elevation of blood glucose or provision of an energy source is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens for patients unable to eat or absorb nutrients enterally. - Fluid replacement therapy to maintain intravascular volume and osmolar balance. - Support of electrolyte balance during surgery or critical care. - Adjunct in diagnostic procedures that require controlled glucose infusion. - Provision of glucose during prolonged fasting or pre‑operative preparation.

Intravenous administration of Glucose B.Braun can be associated with a range of adverse reactions, most of which are mild and transient, while rare events may be serious.

Common: - Transient increase in blood glucose concentration that usually normalizes without intervention. - Mild irritation, redness, or discomfort at the intravenous infusion site. - Nausea, mild abdominal discomfort, or a feeling of fullness. - Fluid overload manifested as peripheral edema in patients with limited cardiac reserve.

Serious: - Marked hyperglycemia that may precipitate osmotic diuresis and dehydration. - Allergic responses ranging from skin rash or urticaria to severe anaphylactic shock. - Significant electrolyte imbalances, such as hyponatremia, hyperkalemia, or shifts in calcium levels.

When prescribing Glucose B.Braun, clinicians should evaluate patient-specific factors and monitor for potential complications.

- Assess baseline blood glucose and adjust infusion rate to avoid hyperglycemia. - Use caution in patients with diabetes mellitus, renal insufficiency, or congestive heart failure. - Monitor fluid balance and signs of overload, especially during prolonged infusions. - Verify compatibility with other intravenous solutions to prevent precipitation. - Observe for signs of allergic reaction during the first administration. - Adjust electrolyte supplementation as needed when large volumes are infused.

Glucose B.Braun may interact with other intravenous medications or conditions that affect glucose metabolism.

Avoid: - Concurrent administration with high‑dose insulin infusions without appropriate glucose monitoring. - Mixing with calcium‑containing solutions that can precipitate when combined with phosphate buffers.

Use with caution: - Co‑administration with diuretics that may alter electrolyte status; monitor sodium and potassium levels. - Use alongside beta‑blockers, which can mask symptoms of hypoglycemia. - Infusion in patients receiving total parenteral nutrition containing other carbohydrate sources; adjust total glucose load. - Administration with glucocorticoids, which can raise blood glucose, requires closer monitoring.